selected publications
- Transplant Outcomes in Myelofibrosis: Impact of Donor Type [Cord Blood Grafts Supported by CD34+ selected Cells (Haplo-Cord) vs Matched Donors]. Transplantation and cellular therapy. 2024 Academic Article GET IT
- Haplo-cord transplant. Realizing the potential of umbilical cord blood grafts. - A review of techniques and analysis of outcomes. Leukemia & lymphoma. 2024 Review GET IT
- Primary central nervous system post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation: a case report. 2024 GET IT
-
XPO1 Enables Adaptive Regulation of mRNA Export Required for Genotoxic Stress Tolerance in Cancer Cells.
Cancer research.
2024
Academic Article
GET IT
Times cited: 6 - Deposition of complement components C5b-9 and MASP2 in tissues is not a feature of GVHD and may assist in discriminating GVHD from thrombotic microangiopathy following allogenic transplantation. Bone marrow transplantation. 2023 Letter GET IT
-
Haploidentical allogeneic stem cell transplantation with post-transplant cyclophosphamide and subsequent kidney transplant for patients with severe sickle cell disease with end-stage kidney disease (ESKD).
Bone marrow transplantation.
2023
Letter
GET IT
Times cited: 14 - Acute Hemolytic Anemia After Hematopoietic Stem Cell Transplantation: An Unusual Invader. 2023 GET IT
- Screening Chest CT Prior to Allogenic Hematopoietic Stem Cell Transplantation. Transplantation and cellular therapy. 2023 Academic Article GET IT
- Pre-hematopoietic stem cell transplant rituximab for Epstein-Barr Virus and post-transplant lymphoproliferative disorder prophylaxis in alemtuzumab recipients. Transplantation and cellular therapy. 2022 Academic Article GET IT
-
Predictors of Covid-19 Vaccination Response After In-Vivo T-Cell-Depleted Stem Cell Transplantation.
Transplantation and cellular therapy.
2022
Academic Article
GET IT
Times cited: 11 -
C5b-9 and MASP2 deposition in skin and bone marrow microvasculature characterize hematopoietic stem cell transplant-associated thrombotic microangiopathy.
Bone marrow transplantation.
2022
Letter
GET IT
Times cited: 1 -
Adenovirus viremia after in vivo T-cell depleted allo-transplant in adults: low lymphocyte counts are associated with uncontrolled viremia and fatal outcomes.
Leukemia & lymphoma.
2021
Academic Article
GET IT
Times cited: 1 - Colonization with Gastrointestinal Pathogens Prior to Hematopoietic Cell Transplantation and Associated Clinical Implications. Transplantation and cellular therapy. 2021 Academic Article GET IT
-
Sequential intensive chemotherapy followed by autologous or allogeneic transplantation for refractory lymphoma.
Leukemia & lymphoma.
2021
Academic Article
GET IT
Times cited: 1 - Allogeneic Transplant Conditioning Regimens for Patients With Non-Hodgkin Lymphoma. JAMA oncology. 2020 Letter GET IT
-
Adoptive immunotherapy with CB following chemotherapy for patients with refractory myeloid malignancy: chimerism and response.
Blood advances.
2020
Academic Article
GET IT
Times cited: 5 -
Impact of a Multiplexed Polymerase Chain Reaction Panel on Identifying Diarrheal Pathogens in Hematopoietic Cell Transplant Recipients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
2020
Academic Article
GET IT
Times cited: 11 -
Hematology and oncology clinical care during the coronavirus disease 2019 pandemic.
CA: a cancer journal for clinicians.
2020
Academic Article
GET IT
Times cited: 18 -
Poor graft function after T cell-depleted allogeneic hematopoietic stem cell transplant.
Leukemia & lymphoma.
2020
Academic Article
GET IT
Times cited: 1 -
Impact of alemtuzumab dosing and low-dose total body irradiation on cytomegalovirus infection in allogeneic hematopoietic stem cell transplantation.
Leukemia & lymphoma.
2020
Letter
GET IT
Times cited: 2 -
Cord blood transplants supported by unrelated donor CD34+ progenitor cells.
Bone marrow transplantation.
2020
Academic Article
GET IT
Times cited: 3 -
KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation.
Blood advances.
2020
Academic Article
GET IT
Times cited: 42 -
Outcomes of Allogeneic Stem Cell Transplant for Elderly Patients with Hematologic Malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2019
Academic Article
GET IT
Times cited: 5 -
Haploidentical vs haplo-cord transplant in adults under 60 years receiving fludarabine and melphalan conditioning.
Blood advances.
2019
Academic Article
GET IT
Times cited: 29 -
A Phase II Multicenter Study of the Addition of Azacitidine to Reduced-Intensity Conditioning Allogeneic Transplant for High-Risk Myelodysplasia (and Older Patients with Acute Myeloid Leukemia): Results of CALGB 100801 (Alliance).
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2019
Academic Article
GET IT
Times cited: 26 -
High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma.
Bone marrow transplantation.
2019
Academic Article
GET IT
Times cited: 12 -
Prophylactic rituximab prevents EBV PTLD in haplo-cord transplant recipients at high risk.
Leukemia & lymphoma.
2019
Academic Article
GET IT
Times cited: 11 -
Adoptive Immunotherapy with Cord Blood for the Treatment of Refractory Acute Myelogenous Leukemia: Feasibility, Safety, and Preliminary Outcomes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2018
Academic Article
GET IT
Times cited: 2 -
Incidence, significance, and persistence of human coronavirus infection in hematopoietic stem cell transplant recipients.
Bone marrow transplantation.
2018
Academic Article
GET IT
Times cited: 35 -
Bortezomib and Immune Globulin Have Limited Effects on Donor-Specific HLA Antibodies in Haploidentical Cord Blood Stem Cell Transplantation: Detrimental Effect of Persistent Haploidentical Donor-Specific HLA Antibodies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2018
Academic Article
GET IT
Times cited: 5 -
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2018
Academic Article
GET IT
Times cited: 163 -
Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome.
British journal of haematology.
2018
Academic Article
GET IT
Times cited: 100 -
Safety and efficacy of plerixafor dose escalation for the mobilization of CD34+ hematopoietic progenitor cells in patients with sickle cell disease: interim results.
Haematologica.
2018
Academic Article
GET IT
Times cited: 51 -
Reduced-Intensity Allogeneic Transplant for Acute Myeloid Leukemia and Myelodysplastic Syndrome Using Combined CD34-Selected Haploidentical Graft and a Single Umbilical Cord Unit Compared with Matched Unrelated Donor Stem Cells in Older Adults.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2017
Academic Article
GET IT
Times cited: 11 -
Validating and implementing the use of an infusion pump for the administration of thawed hematopoietic progenitor cells-a single-institution experience.
Transfusion.
2017
Academic Article
GET IT
Times cited: 1 -
Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic Leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2017
Academic Article
GET IT
Times cited: 24 -
Granulocyte Colony-Stimulating Factor Use after Autologous Peripheral Blood Stem Cell Transplantation: Comparison of Two Practices.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2017
Academic Article
GET IT
Times cited: 15 -
A Phase I Trial of High-Dose Lenalidomide and Melphalan as Conditioning for Autologous Stem Cell Transplantation in Relapsed or Refractory Multiple Myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2017
Academic Article
GET IT
Times cited: 7 -
Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND Study.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2017
Academic Article
GET IT
Times cited: 27 -
The Addition of Low-Dose Total Body Irradiation to Fludarabine and Melphalan Conditioning in Haplocord Transplantation for High-Risk Hematological Malignancies.
Transplantation.
2017
Academic Article
GET IT
Times cited: 10 -
Haplo-cord transplant: HLA-matching determines graft dominance.
Leukemia & lymphoma.
2016
Letter
GET IT
Times cited: 9 -
Cord blood chimerism and relapse after haplo-cord transplantation.
Leukemia & lymphoma.
2016
Academic Article
GET IT
Times cited: 19 -
Prospective assessment of white matter integrity in adult stem cell transplant recipients.
Brain imaging and behavior.
2016
Academic Article
GET IT
Times cited: 19 -
Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide, and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase II Study and CIBMTR Outcomes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2016
Academic Article
GET IT
Times cited: 18 -
Early human herpes virus type 6 reactivation in umbilical cord blood allogeneic stem cell transplantation.
Leukemia & lymphoma.
2016
Academic Article
GET IT
Times cited: 10 - Bendamustine and stem-cell mobilization: not so bad!. Leukemia & lymphoma. 2016 Article GET IT
-
DAS181 for Treatment of Parainfluenza Virus Infections in Hematopoietic Stem Cell Transplant Recipients at a Single Center.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2016
Academic Article
GET IT
Times cited: 39 -
Frequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2016
Academic Article
GET IT
Times cited: 17 -
Allogeneic Transplantation for Patients With Advanced Myelofibrosis: Splenomegaly and High Serum LDH are Adverse Risk Factors for Successful Engraftment.
Clinical lymphoma, myeloma & leukemia.
2016
Academic Article
GET IT
Times cited: 10 -
Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.
Haematologica.
2016
Academic Article
GET IT
Times cited: 36 -
Comparison of Subcutaneous versus Intravenous Alemtuzumab for Graft-versus-Host Disease Prophylaxis with Fludarabine/Melphalan-Based Conditioning in Matched Unrelated Donor Allogeneic Stem Cell Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2015
Academic Article
GET IT
Times cited: 13 -
Clinical and molecular epidemiology of human rhinovirus infections in patients with hematologic malignancy.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
2015
Academic Article
GET IT
Times cited: 33 -
Impact of Prophylactic Levofloxacin on Rates of Bloodstream Infection and Fever in Neutropenic Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2015
Academic Article
GET IT
Times cited: 48 -
Epidemiology and outcomes of invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients in the era of antifungal prophylaxis: a single-centre study with focus on emerging pathogens.
Mycoses.
2015
Academic Article
GET IT
Times cited: 71 -
A novel hematopoietic progenitor cell mobilization and collection algorithm based on preemptive CD34 enumeration.
Transfusion.
2015
Academic Article
GET IT
Times cited: 12 -
How we handled the dextran shortage: an alternative washing or dilution solution for cord blood infusions.
Transfusion.
2015
Academic Article
GET IT
Times cited: 14 -
Hematopoietic stem-cell transplantation for advanced systemic mastocytosis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2014
Academic Article
GET IT
Times cited: 145 -
MPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosis.
Blood.
2014
Academic Article
GET IT
Times cited: 125 -
The emergence of vancomycin-resistant enterococcal bacteremia in hematopoietic stem cell transplant recipients.
Leukemia & lymphoma.
2014
Academic Article
GET IT
Times cited: 31 -
A strategy to reduce donor-specific HLA Abs before allogeneic transplantation.
Bone marrow transplantation.
2014
Letter
GET IT
Times cited: 10 -
A prospective evaluation of changes in brain structure and cognitive functions in adult stem cell transplant recipients.
Brain imaging and behavior.
2013
Academic Article
GET IT
Times cited: 38 -
Human rhinovirus infections of the lower respiratory tract in hematopoietic stem cell transplant recipients.
Transplant infectious disease : an official journal of the Transplantation Society.
2013
Academic Article
GET IT
Times cited: 44 -
A phase I study of CPX-351 in combination with busulfan and fludarabine conditioning and allogeneic stem cell transplantation in adult patients with refractory acute leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2013
Academic Article
GET IT
Times cited: 12 -
A phase 1 study of bendamustine and melphalan conditioning for autologous stem cell transplantation in multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2013
Academic Article
GET IT
Times cited: 30 -
Overcoming the response plateau in multiple myeloma: a novel bortezomib-based strategy for secondary induction and high-yield CD34+ stem cell mobilization.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2013
Academic Article
GET IT
Times cited: 20 -
Peripheral-blood versus bone marrow stem cells.
The New England journal of medicine.
2013
Letter
GET IT
Times cited: 5 -
Avoiding pitfalls in bone marrow engraftment analysis: a case study highlighting the weakness of using buccal cells for determining a patient's constitutional genotype after hematopoietic stem cell transplantation.
Cytotherapy.
2012
Academic Article
GET IT
Times cited: 8 -
Emergence of carbapenem-resistant Enterobacteriaceae as causes of bloodstream infections in patients with hematologic malignancies.
Leukemia & lymphoma.
2012
Academic Article
GET IT
Times cited: 86 -
Autologous stem cell transplant in human immunodeficiency virus-positive patients with lymphoid malignancies: focus on infectious complications.
Leukemia & lymphoma.
2012
Letter
GET IT
Times cited: 3 -
Bortezomib in combination with rituximab, dexamethasone, ifosfamide, cisplatin and etoposide chemoimmunotherapy in patients with relapsed and primary refractory diffuse large B-cell lymphoma.
Leukemia & lymphoma.
2012
Academic Article
GET IT
Times cited: 23 -
Addition of plerixafor to mobilization regimens in autologous peripheral blood stem cell transplants does not affect the correlation of preharvest hematopoietic precursor cell enumeration with first-harvest CD34+ stem cell yield.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2012
Academic Article
GET IT
Times cited: 11 -
Autologous stem cell transplant is feasible in very elderly patients with lymphoma and limited comorbidity.
American journal of hematology.
2012
Letter
GET IT
Times cited: 33 -
Palifermin for the reduction of acute GVHD: a randomized, double-blind, placebo-controlled trial.
Bone marrow transplantation.
2012
Academic Article
GET IT
Times cited: 17 -
Response to second-line therapy defines the potential for cure in patients with recurrent diffuse large B-cell lymphoma: implications for the development of novel therapeutic strategies.
Clinical lymphoma, myeloma & leukemia.
2010
Academic Article
GET IT
Times cited: 39 -
A phase II trial of the epothilone B analog ixabepilone (BMS-247550) in patients with metastatic melanoma.
PloS one.
2010
Academic Article
GET IT
Times cited: 11 -
Clinical and ultrasonic evaluation of spleen size during peripheral blood progenitor cell mobilization by filgrastim: results of an open-label trial in normal donors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2009
Academic Article
GET IT
Times cited: 15 -
Stem cell mobilization with cyclophosphamide overcomes the suppressive effect of lenalidomide therapy on stem cell collection in multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2008
Academic Article
GET IT
Times cited: 103 -
Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapies.
Annals of oncology : official journal of the European Society for Medical Oncology.
2008
Academic Article
GET IT
Times cited: 63 -
Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2007
Academic Article
GET IT
Times cited: 43 -
BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myeloma.
Blood.
2007
Academic Article
GET IT
Times cited: 161 -
Safety and tolerability of velafermin (CG53135-05) in patients receiving high-dose chemotherapy and autologous peripheral blood stem cell transplant.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.
2007
Academic Article
GET IT
Times cited: 13 -
Dose-attenuated radioimmunotherapy with tositumomab and iodine 131 tositumomab in patients with recurrent non-Hodgkin's lymphoma (NHL) and extensive bone marrow involvement.
Leukemia & lymphoma.
2007
Academic Article
GET IT
Times cited: 11 - Stem cell transplantation for myelodysplastic syndromes: the lure of a cure. Current hematologic malignancy reports. 2007 Information Resource GET IT
-
A study of a reduced-intensity conditioning regimen followed by allogeneic stem cell transplantation for patients with hematologic malignancies using Campath-1H as part of a graft-versus-host disease strategy.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2006
Academic Article
GET IT
Times cited: 10 -
Subsequent therapy can be administered after tositumomab and iodine I-131 tositumomab for non-Hodgkin lymphoma.
Cancer.
2006
Academic Article
GET IT
Times cited: 30 -
Combination antibody therapy with epratuzumab and rituximab in relapsed or refractory non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2005
Academic Article
GET IT
Times cited: 157 -
An evaluation of the donor experience in the canadian multicenter randomized trial of bone marrow versus peripheral blood allografting.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2004
Academic Article
GET IT
Times cited: 52 -
A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies.
Blood.
2002
Academic Article
GET IT
Times cited: 275 -
Gingival hyperplasia complicating acute myelomonocytic leukemia.
Journal (Canadian Dental Association).
2000
Information Resource
GET IT
Times cited: 26 -
Remission induction therapy of untreated acute myeloid leukemia using a non-cytarabine-containing regimen of idarubicin, etoposide, and carboplatin.
Cancer.
1998
Academic Article
GET IT
Times cited: 8 - Cytotoxic therapy-induced D-xylose malabsorption and invasive infection during remission-induction therapy for acute myeloid leukemia in adults. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1997 Academic Article GET IT
-
Therapy of untreated acute myeloid leukemia in the elderly: remission-induction using a non-cytarabine-containing regimen of mitoxantrone plus etoposide.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
1996
Academic Article
GET IT
Times cited: 39 -
A phase II study of DuP 937 (Teloxantrone) in metastatic malignant melanoma: a study of the National Cancer Institute of Canada Clinical Trials Group (NCICCTG).
Annals of oncology : official journal of the European Society for Medical Oncology.
1993
Academic Article
GET IT
Times cited: 6 -
Cyclosporine and methylprednisolone for prophylaxis of acute graft-versus-host disease.
Bone marrow transplantation.
1988
Academic Article
GET IT
Times cited: 19 -
The predictive value of in-vitro techniques in acute non-lymphocytic leukemia.
Leukemia research.
1987
Academic Article
GET IT
Times cited: 1